Stevens, Natasha
Taheri, Shiva
Grossi, Ugo
Emmett, Chris
Bannister, Sybil
Norton, Christine
Yiannakou, Yan
Knowles, Charles
,
Article History
Received: 3 October 2023
Accepted: 29 October 2024
First Online: 15 November 2024
Declarations
:
: This study within a trial (SWAT) was approved by the Queen Mary University of London Ethics Committee, QMREC2023a. The overarching clinical trials were approved by London City and East Human Research Ethics Committee; CapaCiTY01 REC 14/LO/1786 ISRCTN11791740, CapaCiTY02: REC 15/LO/0732, ISRCTN11093872, CapaCiTY03: REC 15/LO/0732, ISRCTN11747152. Informed consent was provided by all participants in accordance with the ethics approvals. All methods were carried out according to the clinical trial regulations, local governance requirements and quality assurance procedures including; The Medicines for Human Use (Clinical Trials) Regulations 2004, Good Clinical Practice, Data Protection Act, NHS Caldicott Principles, The UK Research Governance Framework for Health and Social Care, Pragmatic Clinical Trials Unit Standard Operating Procedures.
: Not applicable.
: The authors declare no competing interests.